Urinary Bladder, Overactive: Clinical Trials

1 trial for Urinary Bladder, Overactive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Solifenacin, Mirabegron - Urinary Incontinence in Children
Phase 3RecruitingUniversity of Aarhus2362024-06-272026-06-08

Narrower conditions

Diurnal Enuresis (1)  ·  Urinary Incontinence (1)

Broader conditions

Behavior (1)  ·  Behavioral Symptoms (1)  ·  Elimination Disorders (1)  ·  Enuresis (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Male Urogenital Diseases (1)  ·  Mental Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Urinary Bladder Diseases (1)  ·  Urination Disorders (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Solifenacin Succinate (1)  ·  mirabegron (1)

Sponsors

University of Aarhus (1)

Countries

Denmark (1)

Top investigators

Luise Borch, MD, PhD (1)

Results publications

PMID 40570329